<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1208245745
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CORTIMENT MMX 9 MG PROLONGED RELEASE TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BUDESONIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        9
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        327
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Cosmo S.P.A " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Cosmo S.P.A 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Ferring GmbH 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A07EA06 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cortiment&reg;MMX tablets contain the active ingredient Budesonide. Budesonide belongs to the category of (Corticosteroids). These are used to reduce inflammation.<br />Cortiment&reg;MMX tablets are used in adults to treat:<br />&bull;ulcerative colitis which is an inflammation of the large intestine (colon) and the rectum.<br />&bull;acute episodes of microscopic colitis which is a disease with chronic inflammation of the large intestine (colon) typically with chronic watery diarrhoea</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Cortiment&reg;MMX&reg;<br />Contact your doctor if you experience blurred vision or other visual disturbances.<br />Talk to your doctor or pharmacist before taking Cortiment&reg;MMX:<br />-if you have an infection, such as a virus infection, a bacterial infection or a fungal infection;<br />-if you have ever had high blood pressure;<br />-if you have diabetes;<br />-if you ever had brittle bones;<br />-if you ever had a stomach ulcer;<br />-if you ever had elevated eyeball pressure (glaucoma) or grey cataract;<br />-if a family member has ever had diabetes or elevated eyeball pressure (glaucoma);<br />-if you ever had liver problems;<br />-if you transfer from other cortisone therapy to Cortiment&reg;MMX as this may result in e.g. pain in the musclesand joints, tiredness, headache, nausea, and vomiting;<br />-if you know that you need to be vaccinated;<br />-if you have been treated with a stronger cortisone preparation before starting treatment with Cortiment&reg;MMX,your symptoms may reappear;</p><p>- if you get an infection during the treatment, Cortiment&reg;MMX can hide the signs of infection and the infection may get worse. You may get infections easier during the treatment with Cortiment&reg;MMX, since your body&rsquo;s resistance towards infections may be reduced;<br />- if you are scheduled to undergo surgery soon or are going through a stressful period;<br />- if you have not yet had measles or chicken pox. While taking Cortiment&reg;MMX tablets, try to avoid people with measles or chicken pox. Inform your doctor if you think you have been infected with chicken pox or measles while taking this medicine;<br />- if you or a family member ever had problems with mental health.</p><p>Taking cortisone preparations at high doses and for a prolonged period may affect all parts of the body and in very rare cases psychological problems (see section 4. Possible side effects).<br />If you have any doubts about whether one of the above applies to you, contact your doctor or pharmacist before you take Cortiment&reg;MMX tablets.</p><p><br />Consequences of misuse for doping purposes<br />The use of Cortiment&reg;MMXmay lead to positive results in doping tests. The use of Cortiment&reg;MMX for doping purposes may endanger health.</p><p><br />Other medicines and Cortiment</p><p>Tell your doctor if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is necessary because Cortiment&reg;MMX tablets affect how some medicines work and some medicines may affect howCortiment&reg;MMXworks. Some medicines may increase the effects of Cortiment&reg;MMX and your doctor may wish to monitoryou carefully if you are taking these medicines (including some medicines for HIV; ritonavir, cobicistat).<br />It is particularly important that you tell your doctor or pharmacist if you are taking, have recently taken or might take one of the following medicines:<br />- Ketoconazole or itraconazole, which are substances used to treat fungal infections;<br />- Medicines used for HIVtreatment (e.g. Ritonavir, nelfinavir, cobicistat-containing products)<br />- Carbamazepine, which is used for treatment of epilepsy;<br />- Cardiac glycosides and diuretics;<br />- Medicines that contain oestrogens, such as hormone replacement therapy (HRT) and some oral contraceptives;<br />- Cholestyramine, which is used to lower cholesterol levels or treat itching caused by liver problems, or antacidswhich is used to neutralise the acid made by your stomach.</p><p>Cortiment&reg;MMX with food, drink and alcohol<br />Do not drink grapefruit juice when taking Cortiment&reg;MMX tablets. This may affect the working of the medicine.</p><p><br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><br />Driving and using machines<br />It is unlikely that Cortiment&reg;MMXwill affect your ability to drive and use machines. Care is required because this type of medicine may sometimes cause dizziness or fatigue.</p><p><br />Cortiment&reg;MMX contains lactose and lecithin (soya oil)<br />Cortiment&reg;MMX containsLactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Cortiment&reg;MMX.<br />Cortiment&reg;MMX contains Lecithin (soya oil). If you are allergic to peanuts or soya, do not use this medicinal product.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.<br />- The recommended dose for ulcerative colitis and microscopic colitis is 1 tablet in the morning before or with breakfast.<br />- Swallow the tablet whole with a glass of water; the tablet must not be broken, crushed or chewed.<br />- Usually you will take this medicine daily for a maximum of 8 weeks. Your doctor may then gradually lower the number of times you take the medicine.<br />- Keep taking Cortiment&reg;MMX tablets as your doctor has told you, even if you start feeling better.</p><p>Additional information when taking Cortiment&reg;MMX tablets: If you will undergo surgery soon or are going through a stressful period, the doctor may ask you to take other steroid tablets as well.<br />Use in patients with reduced kidney or liver function: Cortiment&reg;MMX was not studied specifically in patients with kidney or liver problems.Talk to your doctor.<br />Use in children: Cortiment&reg;MMX tablets are not recommended for use in children.</p><p><br />If you take more Cortiment&reg;MMX than you should: If you take more Cortiment&reg;MMX tablets than you should, inform your doctor immediately.</p><p><br />If you forget to take Cortiment&reg;MMX<br />- If you forget to take a Cortiment&reg;MMX tablet, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose.<br />- Do not take a double dose to make up for a forgotten tablet.</p><p><br />If you stop taking Cortiment&reg;MMX<br />Do not stop taking Cortiment&reg;MMX tablets without discussing it with your doctor first. You may need to stop the treatment gradually. If you suddenly stop taking the medicine, you may become ill.<br />If you have any further questions about the use of this medicine, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />If you have an allergic reaction, contact your doctor immediately or call the emergency physician. Signs may include hives or swelling of the face, lips, mouth, tongue and throat. This can make it difficult to breathe.<br />The following side effects may occur when taking Cortiment&reg;MMX;most of the side effects mentioned below can also be expected with other steroid treatment.</p><p><br />Common (may affect up to 1 in 10 people):<br />- Cushing-like symptoms, such as a round face, acne, weight gain and a tendency to bruise easily<br />- Low potassium levels in the blood, which can cause muscle weakness or fatigue, thirst or a tingling sensation<br />- Change in behaviour, such as nervousness, insomnia and mood swings<br />- Depression<br />- Headache<br />- Pounding heart beats (palpitations)<br />- Nausea<br />- Stomach ache<br />- Bloated abdomen<br />- Dry mouth<br />- Indigestion (dyspepsia)<br />- Skin rash or itchiness<br />- Acne<br />- Muscle pain, muscle cramps<br />- Heavy or irregular menstruation in women<br />- Extreme tiredness (fatigue)<br />- Decrease of the hormone cortisol in the blood.</p><p><br />Uncommon (may affect up to 1 in 100 people):<br />- Influenza<br />-Rise in white blood cells<br />- Change in behaviour, such as mood swings<br />- Feeling of restlessness with hyperactivity<br />- Anxiety<br />- Dizziness<br />- Shaking<br />- Flatulence<br />- Back pain<br />- Muscle spasms<br />- Swelling of the legs</p><p><br />Rare (may affect up to 1 in 1,000 people):<br />- Aggression<br />- Glaucoma (increased pressure in the eye)<br />- Opacity of the lens or capsule of the eye (cataract)<br />- Blurred vision.<br />- Purple or black-and-blue spots on the skin</p><p><br />Very rare (may affect up to 1 in 10,000 people):</p><p>- A serious allergic reaction (called anaphylaxis) which can lead to breathing difficulties and potential shock<br />Some of the side effects mentioned above are typical for steroid medication and may occur depending on your dose, period of treatment, whether you have or have had treatment with other cortisone preparations, and your individual susceptibility.<br />Psychological problems may develop when taking steroids like Cortiment&reg;MMX.Discuss it with your doctor if you (or someone who uses this medicine) have (has) symptoms of psychological problems. This is particularly important if you are depressed and may be thinking about committing suicide. In very rare cases, psychological problems have developed when high doses were taken for a long time.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&deg;C.<br />Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the carton and on the blister pack after EXP. The expiry date refers to the last day of that month.<br />Do not throw away any medicines via wastewater (e.g. not via toilet or sink). Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredientis Budesonide. Each tablet contains 9 mg of Budesonide.<br />The other ingredients (excipients) are:<br />- Tablet core: Stearic Acid, Lecithin (soya), Microcrystalline cellulose, Hydroxypropylcellulose, Lactose Monohydrate, Silica,ColloidalHydrated,Magnesium stearate.<br />- Film coating: Methacrylic acid-methylmethacrylate copolymer (1:1), Methacrylic acid-methylmethacrylate copolymer (1:2), Talc, Titanium Dioxide, Triethylcitrate.</p><p><br />Excipients with known effect:<br />50 mg Lactose Monohydrate and 10 mg Lecithin (derived from soya oil).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cortiment®MMX is supplied in white to off-white, round, double convex tablets with a film coating, and 'MX9' engraved on one side of the tablet. The tablets are supplied in blister packs with aluminium press-through foil in a cardboard carton.
This medicine is available in packs of: pack of 10 tablets (10×1), pack of 20 tablets (10×2), pack of 30 tablets (10×3), pack of 50 tablets (10×5), pack of 60 tablets (10×6), pack of 80 tablets (10×8).
Not all pack sizes maybe marketed in your country .
Prescription Only Medicine
List I

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder<br />Ferring GmbH, Wittland 11, 24109 Kiel, Germany.<br />Manufacturing Site<br />Cosmo S.p.A., Via C. Colombo, 1-20045 Lainate, Milan, Italy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                September 2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>تحتوي أقراص كورتيمينت ام ام اكس على مادة فعالة تسمى بيوديزونايد.بيوديزونايد ينتمي إلى مجموعة دوائية تسمى(الكورتيكوستيرويدات)، التي تستخدم من أجل تخفيف الالتهاب.<br />تستخدم أقراص كورتيمينت ام ام اكس من قبل البالغين من أجل معالجة:<br />- التهاب&nbsp;التهاب القولون التقرحي والذي هو التهاب الأمعاء الغليظة ( القولون)&nbsp; والمستقيم.</p><p>-&nbsp;النوبات الحادة من التهاب القولون المجهري وهو الالتهاب المزمن في الأمعاء الغليظة (القولون) يصاحبه بالعادة إسهال مائي مزمن.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تستخدم كورتيمينت ام ام اكس</strong></p><p>- إذا كنت تعاني من فرط الحساسية من البيوديزونايد أو أحد&nbsp;المكونات الأخرى لهذا الدواء المدرجة في القسم 6<br />- إذا كنت تعاني من فرط الحساسية من الفستق أو فول الصويا، إذ يحتوي هذا الدواء الطبي على الليسيثين المشتق من زيت الصويا.<br /><strong>التحذيرات والاحتياطات</strong><br />اتصل بطبيبك إذا عانيت من عدم وضوح في الرؤية أو اضطرابات بصرية أخرى. تحدث إلى طبيبك أو الصيدلي قبل تناول كورتيمينت ام ام اكس:<br />- إذا كنت تعاني من عدوى، مثلا عدوى فيروسية، عدوى بكتيرية أو عدوى فطرية؛<br />- إذا عانيت من ارتفاع ضغط الدم؛<br />- إذا كنت تعاني من مرض السكري؛<br />- إذا عانيت من هشاشة العظام؛<br />- إذا عانيت من قرحة في المعدة؛<br />- إذا عانيت من ارتفاع الضغط في مقلة العين (مرض الزرق)أو الساد الرمادي؛<br />- إذا كان أحد أفراد العائلة قد عانى من مرض السكري أو ارتفاع الضغط في مقلة العين (مرض الزرق)؛<br />- إذا عانيت من مشاكل في الكبد؛<br />- إذا تم نقل علاجك من كورتيزون آخر إلى كورتيمينت ام ام اكس حيث سيسبب ذلك كمثال ألم في العضلات والمفاصل، التعب، الصداع، الغثيان والقيء؛<br />- إذا كنت تعلم بأنك بحاجة لأخذ مطعوم؛<br />- إذا كنت تتعالج بمستحضر كورتيزون أقوى قبل البدء بالعلاج بكورتيمينت ام ام اكس فإن الأعراض ستظهر من جديد؛<br />- إذا أصبت بعدوى خلال العلاج، فإن كورتيمينت ام ام اكس يمكن أن يخفي علامات العدوى وقد تزداد العدوى سوءاً. قد تحصل على العدوى بشكل أسهل أثناء العلاج بكورتيمينت ام ام اكس، حيث أن مقاومة جسدك للعدوى قد تصبح أقل؛<br />- إذا كان من المقرر أن تخضع لعملية جراحية قريباً وتمر خلال فترة مجهدة؛<br />- إذا لم تصبك الحصبة أو جدري الماء. أثناء تناول كورتيمينت ام ام اكس<br />حاول تجنب الأشخاص المصابين بالحصبة أو جدري الماء. أخبر طبيبك إذا كنت تعتقد أنك مصاب بالحصبة أو بجدري الماء أثناء تناول هذا الدواء؛<br />- إذا كنت أنت تعاني أو أحد أفراد العائلة من مشاكل نفسية.</p><p><br />استخدام مستحضرات الكورتيزون في جرعات عالية ولفترة طويلة قد تؤثر على جميع أجزاء الجسم وفي حالات نادرة جداً قد تسبب مشاكل نفسية (انظر إلى قسم ٤ التأثيرات الجانبية المحتملة).<br />راجع طبيبك أو الصيدلي قبل أخذ كورتيمينت ام ام اكس إذا كانت لديك شكوك بأنك تعاني من أحد البنود الواردة أعلاه.<br /><strong>عواقب سوء استخدام لغايات تعاطي المنشطات</strong><br />إن استخدام كورتيمينت ام ام اكس قد يؤدي إلى نتائج إيجابية في اختبار الكشف عن المنشطات. إن استخدام كورتيمينت ام ام اكس لغرض تحفيز النشاط قد يعرض الصحة للخطر.<br /><strong>الأدوية الأخرى وكورتيمينت ام ام اكس</strong><br />أخبر طبيبك إذا كنت تأخذ أو أخذت مؤخراً أو قد تأخذ أي أدوية أخرى، بما في ذلك الأدوية التي تم الحصول عليها بدون وصفة طبية.<br />هذا مهم حيث أن كورتيمينت ام ام اكس قد يؤثر على عمل بعض الأدوية وبعض الأدوية قد تؤثر على عمل كورتيمينت ام ام اكس. قد تقوم بعض الأدوية بزيادة تأثير كورتيمينت ام ام اكس، وقد يرغب طبيبك في مراقبتك بعناية إذا كنت تأخذ هذه الأدوية (بما في ذلك بعض الأدوية لفيروس نقص المناعة البشرية؛ ريتونافير وكوبيسيستات).</p><p><br />من المهم أن تخبر طبيبك أو الصيدلي إذا كنت تأخذ أو أخذت مؤخراً أو قد تأخذ أحد الأدوية التالية:<br />- كيتوكونازول أو ايتراكونازول وهي مواد تستخدم في علاج العدوى الفطرية؛<br />- أدوية تستخدم لفيروس نقص المناعة البشرية (مثال ريتونافير،نيلفينافير ومستحضرات تحتوي على كوبيسيستات)؛<br />- كاربامازيبين الذي يستخدم من أجل علاج الصرع؛<br />- الغليكوزيدات القلبية أو مدرات البول؛<br />- الأدوية التي تحتوي على الاستروجين، مثل العلاج التعويضي بالهرمونات وبعض موانع الحمل التي تؤخذ عن طريق الفم؛<br />- كوليستايرمين الذي يستخدم في تقليل مستويات الكوليسترول أو لعلاج الحكة الناتجة عن مشاكل الكبد، أو مضادات الحموضة التي تستخدم لمعادلة الحمض الذي تفرزه معدتك.<br /><strong>تناول كورتيمينت ام ام اكس مع الطعام والشراب والكحول</strong><br />لا تشرب عصير الجريب فروت عند أخذ أقراص كورتيمينت ام ام اكس لأنه&nbsp;&nbsp;قد يؤثر على عمل الدواء.<br /><strong>الحمل والرضاعة</strong><br />يرجى استشارة طبيبك أو الصيدلي قبل تناول هذا الدواء إذا كنت حامل أو مرضعة، أو تعتقدين أنك حامل أو تخططين لذلك.<br /><strong>القيادة واستخدام الآلات</strong><br />إنه من غير المتوقع أن يؤثر كورتيمينت ام ام اكس في قدرتك على القيادةواستخدام الآلات. يتطلب تناوله عناية خاصة لأن هذا النوع من الدواء قد يسبب دوخة أو التعب أحياناً.<br /><strong>يحتوي كورتيمينت ام ام اكس على اللاكتوز والليسيثين (زيت الصويا)</strong><br />تحتوي أقراص كورتيمينت ام ام اكس على اللاكتوز. يرجى استشارة طبيبك قبل تناول هذا الدواء، إذا تم اخبارك بأنك لا تتحمل بعض السكريات.<br />يحتوي كورتيمينت ام ام اكس على الليسيثين (زيت الصويا). إذا كان لديكحساسية من الفستق أو فول الصويا، لا تستخدم هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يرجى تناول كورتيمينت ام ام اكس تماماً كما وصفه الطبيب. قم باستشارة الطبيب إذا كنت غير متأكداً.<br />- الجرعة الموصى بها هي قرص واحد في الصباح قبل وجبة الإفطار أو معها.<br />- ابلع القرص كاملاً مع كوب من الماء؛ ويجب عدم تكسير أو سحق أو مضغ القرص.<br />- عادةً سوف تأخذ هذا الدواء يومياً لمدة أقصاها ثمانية أسابيع. سيقوم طبيبك بعد ذلك بتخفيض عدد مرات تناولك لهذا الدواء تدريجياً.<br />- يرجى الاستمرار في تناول كورتيمينت ام ام اكس كما أخبرك طبيبك حتى إذا شعرت بأنك في صحة أفضل.<br /><strong>معلومات إضافية أثناء تناول أقراص كورتيمينتام ام اكس:</strong> قد يطلب منك الطبيب تناول أقراص من الستيرويدات الأخرى إذا كنت ستخضع لعملية جراحية قريباً أو كنت تمر في فترة مرهقة.<br /><strong>الاستخدام لدى المرضى الذين يعانون من قصور في وظيفة الكلى أو الكبد:</strong> لم يتم دراسة أقراص كورتيمينت ام ام اكس خصيصاً في المرضى الذين يعانون من مشاكل في الكلى أو الكبد. تحدث إلى طبيبك.<br /><strong>الاستخدام لدى الأطفال:</strong> لا ينصح باستخدام أقراص كورتيمينت ام ام اكس لدى&nbsp;الأطفال.<br /><strong>إذا تناولت كورتيمينت ام ام اكس أكثر مما يجب:</strong> يرجى إبلاغ طبيبك فوراً إذا كنت تناولت أقراص كورتيمينت ام ام اكس أكثر مما يجب</p><p><strong>إذا نسيت تناول جرعة من كورتيمينت ام ام اكس</strong><br />- إذا نسيت تناول جرعة من كورتيمينتام ام اكس خذها حالما تتذكر. لا تتناول الجرعة المنسية إذا كان الوقت قريباً من الجرعة التالية.<br />- لا تأخذ جرعة مضاعفة لتعويض القرص المنسي.<br /><strong>إذا توقفت عن تناول كورتيمينت ام ام اكس</strong><br />لا تتوقف عن تناول أقراص كورتيمينت ام ام اكس من دون استشارة<br />طبيبك أولاً. قد تحتاج إلى وقف الدواء تدريجياً. وقد تصبح مريضاً إذا توقفت عن تناول الدواء بشكل مفاجئ.<br />للاستفسار أو للمزيد من المعلومات عن استخدام هذا الدواء، يرجى استشارة طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، قد يسبب هذا الدواء أعراض جانبية مع أنها قد لا تصيب جميع الأشخاص<br />إذا ظهر لديك أحد ردود الفعل التحسسية، راجع طبيبك فورا أو قم بالاتصال مع طبيب الطوارئ. وقد تشمل الأعراض الشرى أو التورم في<br />الوجه والشفتين والفم واللسان والحلق، مما يؤدي إلى صعوبة في التنفس.</p><p><br />قد تظهر الأعراض التالية أثناء تناول كورتيمينتام ام اكس. معظم الآثار الجانبية متوقعة عند العلاج بالستيرويدات الأخرى.<br /><strong>شائعة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص):<br />- أعراض شبيهة بمرض كوشينغ، مثل الوجه المستدير وحب الشباب وزيادة الوزن وقابلية الإصابة بالكدمات بسهولة؛<br />- انخفاض مستويات البوتاسيوم في الدم الذي قد يسبب ضعف العضلات أو التعب، والعطش أو الإحساس بالوخز؛<br />- التغير في السلوك كالعصبية والأرق وتقلب المزاج؛-</p><p>-الاكتئاب؛<br />- الصداع؛<br />- خفقان القلب؛<br />- الغثيان؛<br />- ألم في المعدة؛<br />- انتفاخ البطن؛<br />- جفاف الفم؛<br />- عسر الهضم؛<br />- طفح جلدي أو حكة؛<br />- حب الشباب؛<br />- ألم العضلات، تشنجات العضلات؛<br />- حيض ثقيل أو غير منتظم لدى النساء؛<br />- التعب الشديد؛<br />- انخفاض هرمون الكورتيزول في الدم.</p><p><br /><strong>غير شائعة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل 100 شخص):<br />- الأنفلونزا؛<br />- ارتفاع نسبة كريات الدم البيضاء؛<br />- تغير في السلوك، مثل تقلب المزاج؛<br />- الشعور بعدم الارتياح مع فرط النشاط؛<br />- القلق؛<br />- دوخة؛<br />- الرعاش؛<br />- انتفاخ؛<br />- ألم في الظهر؛<br />- تشنجات العضلات؛<br />- تورم في الساقين.<br /><strong>نادرة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل 1.000 شخص):<br />- عدوانية؛<br />- الزرق (ارتفاع ضغط العين)؛<br />- تعتيم العدسة أو حدقة العين (الساد)؛<br />- رؤية غير واضحة؛<br />- بقع نهدية أو سوداء وزرقاء على الجلد.<br /><strong>نادرة جداً</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل 10.000 شخص):<br />- حساسية مفرطة (تسمى التفاعل التحسسي) التي قد تؤدي الصعوبات في التنفس واحتمالية حدوث صدمات.<br />بعض الآثار الجانبية المذكورة أعلاه هي مماثلة للآثار الجانبية لأدوية الستيرويدات، ويمكن أن تحدث اعتماداً على الجرعة، فترة العلاج، إذا كنت تتعالج او تعالجت مع غيرها من مستحضرات الكورتيزون، وقابليتك الفردية.<br />قد تظهر مشاكل نفسية عند أخذ السترويدات مثل كورتيمينت ام ام اكس. يرجى استشارة طبيبك إذا كنت تعاني (أو يعاني شخص آخر يستخدم هذا الدواء) من أعراض المشاكل النفسية. ويعتبر هذا هاماً على وجه الخصوص إذاكنت مكتئب وتفكر في الإقدام على الانتحار. فقد ظهرت المشاكل النفسية في حالات نادرة جدا عند أخذ جرعات عالية لمدة طويلة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ في درجة حرارة أقل من 30 درجة مئوية. يُحفظ هذا الدَّواء بعيدًا عن رؤية ومتناول الأطفال.<br />لا يستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العلبة<br />يشير تاريخ الانتهاء إلى .EXP الخارجية والداخلية للدواء بعد كلمة اليوم الأخير من ذلك الشهر.<br />لا تتخلص من الأدوية عن طريق مياه الصرف الصحي&nbsp;مثل (المرحاض أو المغسلة). اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعدبحاجة إليها. سوف تساعد هذه الإجراءات في حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما هي محتويات كورتيمينت ام ام اكس<br />المادة الفعالة في هذا الدواء هي بيوديزونايد. ويحتوي كل قرص على9 مغ من بيوديزونايد.<br />المكونات الأخرى (السواغات) في هذا الدواء هي:<br />- <strong>نواة القرص:</strong> حامض ستياريك، الليسيثين (صويا)، السيلولوز<br />البلوري الدقيق، هيدروكسي بروبيل السيلولوز، اللاكتوز أحادي الهيدرات، السيليكا الغروية المميهة وستيارات المغنيسيوم.<br />-<strong> تغليف القرص</strong>: حامض الميثاكريليك-ميثيل ميثاكريلات الكوبوليمر&nbsp;،( 1:1 )، حامض الميثاكريليك-ميثيل ميثاكريلات الكوبوليمر ( 2:1 )<br />التالك، ثاني أكسيد التيتانيوم وثلاثي إيثيل السيترات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>سواغات ذات تأثير معلوم:</strong><br />-50 مغ من سكر اللاكتوز أحادي الهيدرات و 10 مغ الليسيثين (المشتق من زيت الصويا).<br /><strong>ما هو الشكل الصيدلاني لكورتيمينت ام ام اكس وحجم عبوته</strong><br />يتم بيع كورتيمينت ام ام اكس كأقراص بيضاء إلى شبه بيضاء، مستديرة و محدبة الوجهين، و مغلفة مع &quot;MX9&quot; محفور على أحد الوجهين.&nbsp;<br />ويتم بيع الأقراص في مجموعات شرائح مضغوطة عبر رقائق الألمنيوم داخل علبة كرتونية.<br />يتواجد هذا الدواء كعبوة تحتوي على: عبوة تحتوي على 10 أقراص ( 10 1x ) ،عبوة تحتوي على 20 قرص&nbsp;( 10 2x ) ،عبوة تحتوي على 30 قرص&nbsp;( 10 3x ) ،عبوة تحتوي على 50 قرص&nbsp;&nbsp;( 10 5x )&nbsp;عبوة تحتوي على&nbsp;60 قرص&nbsp;( 10 6x )&nbsp;&nbsp;أو&nbsp; عبوة تحتوي على 80 قرص&nbsp;( 10 8x )<br />قد لا تكون جميع العبوات مسوقة في بلدك.</p><p>یوصف بموجب وصفة طبیة.</p><p>&nbsp;القائمة I</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>صاحب حق التسويق:<br />فرينغ جي ام بي اتش، ويتلاند 11, 24109&nbsp;كييل، ألمانيا</p><p>المصنع المعبئ الأولي و الثانوي ومحرر الحصص:<br />&nbsp;كوسمو اس بي ايه، فيا سي كولمبو، 1-20045&nbsp;لانيت، ميلانو،&nbsp;إيطاليا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تاريخ مراجعة النص: ايلول/سيبتمبر 2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cortiment®MMX® 9 mg prolonged release tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One tablet contains 9 mg of budesonide.
Excipients with known effect:
50 mg Lactose monohydrate; lecithin, derived from soya oil.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prolonged release tablet
White to off-white, round, biconvex, film-coated, gastro-resistant tablet, approximately 9.5 mm diameter,
approximately 4.7 mm thickness, debossed on one side with “MX9”.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In adults for induction of remission in patients with mild to moderate active ulcerative colitis (UC) where 5-ASA&nbsp;treatment is not sufficient</p><p>In adults for induction of remission in patients with active microscopic colitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br /><u>Adults</u><br />Ulcerative colitis and microscopic colitis:<br />The recommended daily dose for induction of remission is one 9 mg tablet in the morning, for up to 8 weeks.<br />When treatment is discontinued, it may be useful to gradually reduce the dose (for more details on treatment discontinuation, see section 4.4).<br /><u>Paediatric population</u><br />The safety and efficacy of Cortiment 9 mg prolonged release tablets in children aged 0-18 years have not yet been established. No data are available, therefore the use in paediatric population is not recommended until further data become available.<br /><u>Elderly</u><br />No special dose adjustment is recommended. However, experience of the use of Cortiment in the elderly is limited.<br /><u>Hepatic and renal impairment population</u><br />Cortiment 9 mg was not studied in patients with hepatic and renal impairment, therefore caution should be exercised in the administration and monitoring of the product in these patients.<br /><u>Method of administration</u><br />One tablet of Cortiment 9 mg is taken orally in the morning, with or without food. The tablet should be swallowed with a glass of water and must not be broken, crushed or chewed as the film coating is intended to&nbsp;ensure a prolonged release.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to budesonide, soya, peanut or to any of the excipients listed in section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cortiment tablets should be used with caution in patients with infections, hypertension, diabetes mellitus, osteoporosis, peptic ulcer, glaucoma or cataracts or with a family history of diabetes or glaucoma or with any other condition where the use of glucocorticoids may have unwanted effects</p><p><br />Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare condition diseases such as Central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.<br />Reduced liver function may affect the elimination of glucocorticoids including budesonide, causing higher systemic exposure. Be aware of possible systemic side effects. Potential systemic effects include glaucoma.</p><p><br />When treatment is to be discontinued, it may be useful to gradually reduce the dose at the discretion of the treating physician.</p><p><br />Treatment with Cortiment tablets results in lower systemic steroid levels than conventional oral glucocorticoid therapy. Transfer from other steroid therapy may result in symptoms relating to the change in systemic steroid levels. Some patients may feel unwell in a non-specific way during the withdrawal phase, e.g., pain in muscles and joints. A general insufficient corticosteroid effect should be suspected if, in rare cases, symptoms such as tiredness, headache, nausea and vomiting should occur. In these cases a temporary increase in the dose of systemic corticosteroids is sometimes necessary.<br />As corticosteroids are known to have immunological effects the co-administration of Cortiment tablets is likely to reduce the immune response to vaccines.<br />Concomitant administration of ketoconazole or other potent CYP3A4 inhibitors should be avoided. If this is not possible, the period between treatments should be as long as possible and a reduction of the Cortiment dose could also be considered (see also section 4.5). Following significant intake of grapefruit juice (which inhibits CYP3A4 activity predominantly in the intestinal mucosa), the systemic exposure for oral budesonide increased by approximately twofold. As with other drugs primarily being metabolised through CYP3A4, regular ingestion of grapefruit or grapefruit juice simultaneously with budesonide administration should be avoided (other juices such as orange juice or apple juice do not inhibit CYP3A4 activity). See also section 4.5.<br />The use of Cortiment may lead to positive results in doping tests.<br />The use of Cortiment for doping purposes may endanger health.</p><p>Cortiment contains lecithin (soya oil). If a patient is hypersensitive to peanut or soya, this medicine should not be used.</p><p><br />Cortiment tablets contain lactose monohydrate and should not be taken by patients with rare hereditary problems such as galactose intolerance, the complete Lapp lactase deficiency or glucose-galactose malabsorption.</p><p><br />The following warnings and precautions have been generally identified for corticosteroids:<br />&bull; Adrenocortical suppression has been observed when patients are transferred from systemic corticosteroid treatment with higher systemic effect.<br />&bull; Suppression of the inflammatory response and immune system increases the susceptibility to infections.<br />&bull; Corticosteroids may cause suppression of the HPA axis and reduce the stress response. Where patients are subject to surgery or other stresses, supplementary systemic corticosteroid treatment is recommended.<br />&bull; Chicken pox and measles may follow a more serious course in patients on oral glucocorticoids. Particular care should be taken to avoid exposure in patients who have not previously had these diseases. If patients are infected or suspected of being infected, consider reduction or discontinuation of glucocortiocosteriods treatment at the discretion of the treating physician.<br />&bull; Systemic effects of steroids may occur, particularly when prescribed at high doses and for prolonged periods. Such effects may include Cushing&#39;s syndrome, adrenal suppression, growth retardation, decreased bone mineral density, cataract, glaucoma and very rarely a wide range of psychiatric/behavioural effects (see section 4.8).<br />&bull; Particular care is required when considering the use of systemic corticosteroids in patients with current or previous history of severe affective disorders in the patient or any first degree relatives.<br />&bull; Replacement of high systemic effect corticosteroid treatment sometimes unmasks allergies, e.g. rhinitis and eczema that were previously controlled by the systemic drug.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.<br />Budesonide is primarily metabolized by cytochrome P450 3A4 (CYP3A4). Inhibitors of this enzyme are e.g. ketoconazole, itraconazole, HIV protease inhibitors (including cobicistat-containing products) and grapefruit juice. Co-treatment with CYP3A inhibitors is expected to increase systemic exposure to budesonide several times and the risk of systemic side effects (see section 4.4). The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid side-effects. If treatments are combined, the period between dosing of the combined treatments should be as long as possible and a reduction of the budesonide dose could also be considered. Budesonide is unlikely to inhibit other drugs metabolized via CYP3A4, since budesonide has low affinity to the enzyme.<br />Concomitant treatment with CYP3A4 inducers such as carbamazepine may reduce budesonide exposure, which may require a dose increase.<br />Corticosteroid interactions that may present a significant hazard to selected patients are those with heart glycosides (increased effect due to reduced potassium levels) and diuretics (increased elimination of potassium).<br />Increased plasma concentrations of and enhanced effects of corticosteroids have been observed in women also treated with oestrogens and contraceptive steroids, but no such effect has been observed with budesonide and concomitant intake of low-dose combination oral contraceptives.</p><p>Although not studied, concomitant administration of cholestyramine or antacids may reduce budesonide uptake, in common with other drugs. Therefore these preparations should not be taken simultaneously, but at least two hours apart.<br />At recommended doses, omeprazole does not affect the pharmacokinetics of oral budesonide, whereas cimetidine has a slight but clinically insignificant effect.<br />Because adrenal function may be suppressed, an ACTH stimulation test for diagnosing pituitary insufficiency might show false results (low values).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u><br />Data on use of inhaled budesonide in a very large number of exposed pregnancies indicate no adverse effects. Although there are no data of outcomes of pregnancies after oral administration, the bioavailability after oral administration is low. In animal experiments, at high exposures, corticosteroids proved to be harmful (see section 5.3). Cortiment should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.<br /><u>Breast-feeding</u><br />Budesonide is excreted in breast milk.<br />Maintenance treatment with inhaled budesonide (200 or 400 micrograms twice daily) in asthmatic nursing women results in negligible systemic exposure to budesonide in breast-fed infants.<br />In a pharmacokinetic study the estimated daily infant dose was 0.3% of the daily maternal dose for both dose levels, and the average plasma concentration in infants was estimated to be 1/600th of the concentrations observed in maternal plasma, assuming complete infant oral bioavailability.<br />Budesonide concentrations in infant plasma samples were all less than the limit of quantification. Based on data from inhaled budesonide and the fact that budesonide exhibits linear PK properties within the therapeutic dosage intervals after inhaled, oral and rectal administrations, at therapeutic doses of budesonide, exposure to the suckling child is anticipated to be low. These data support continued use of budesonide, oral and rectal administrations, during breast-feeding.<br /><u>Fertility</u><br />There is no data on the effect of Cortiment on fertility in humans. There were no effects on fertility in rats after&nbsp;treatment with budesonide</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects of Cortiment on the ability to drive and use machines have been performed.<br />When driving vehicles or using machines it should be taken into account that occasionally dizziness or tiredness may occur (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions reported in clinical trials with Cortiment are presented in Table 1. Adverse drug reactions reported for the therapeutic class are presented in Table 2. In Phase II and III clinical trials, the incidence of adverse events for Cortiment tablets, at the recommended dose of 9 mg/day, was comparable to placebo. Most adverse events were of mild to moderate intensity and of a non-serious nature.</p><p><br />Adverse reactions reported are listed according to the following frequency: Very common (&ge; 1/10); common (&ge;1/100 to &lt; 1/10); uncommon (&ge; 1/1,000 to &lt; 1/100); rare (&ge; 1/10,000 to &lt; 1/1,000) and very rare (&lt; 1/10,000).&nbsp;</p><p>Table 1: Cortiment drug-related adverse reactions reported during clinical trials with more than one case<br />(N=255)</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td style="width:234px">MedDRA System Organ Classification</td><td style="width:264px"><p>Preferred Term of Adverse Drug Reaction</p><p><strong>Common</strong></p></td><td style="width:264px"><p>Preferred Term of Adverse Drug Reaction</p><p><strong>Uncommon</strong></p></td></tr><tr><td style="width:234px">Infections and infestations</td><td style="width:264px">&nbsp;</td><td style="width:264px">Influenza</td></tr><tr><td style="width:234px">Blood and lymphatic system disorders</td><td style="width:264px">&nbsp;</td><td style="width:264px">Leukocytosis</td></tr><tr><td style="width:234px">Psychiatric disorders</td><td style="width:264px">Insomnia</td><td style="width:264px">Mood altered</td></tr><tr><td style="width:234px">Nervous system disorders</td><td style="width:264px">Headache</td><td style="width:264px">Dizziness</td></tr><tr><td style="width:234px">Gastrointestinal disorders</td><td style="width:264px">Nausea,<br />Abdominal pain upper, Abdominal distension,<br />Abdominal pain,<br />Dry mouth,<br />Dyspepsia</td><td style="width:264px">Flatulence</td></tr><tr><td style="width:234px">Skin and subcutaneous&nbsp;tissue disorders</td><td style="width:264px">Acne</td><td style="width:264px">&nbsp;</td></tr><tr><td style="width:234px">Musculoskeletal and connective tissue disorders</td><td style="width:264px">Myalgia</td><td style="width:264px">Back pain,<br />Muscle spasms</td></tr><tr><td style="width:234px">General disorders and administration site conditions</td><td style="width:264px">Fatigue</td><td style="width:264px">Peripheral oedema</td></tr><tr><td style="width:234px">Investigations</td><td style="width:264px">Blood cortisol decrease</td><td style="width:264px">&nbsp;</td></tr></tbody></table><p>Table 2 Events reported for the therapeutic class (intestinal anti-inflammatory agents, corticosteroids&nbsp;acting locally, budesonide)</p><table border="1" cellspacing="1" cellpadding="1" style="width:710px"><tbody><tr><td style="text-align:center; width:211px"><strong>MedDRA System Organ Classification</strong></td><td style="text-align:center; width:125px"><strong>Common</strong></td><td style="text-align:center; width:103px"><strong>Uncommon</strong></td><td style="text-align:center; width:102px"><strong>Rare</strong></td><td style="text-align:center; width:167px"><strong>Very Rare</strong></td></tr><tr><td style="width:211px">Immune system disorders</td><td style="width:125px">&nbsp;</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">Anaphylactic reaction</td></tr><tr><td style="width:211px">Endocrine disorders</td><td style="width:125px">Cushingoid features</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">Growth retardation in children*</td></tr><tr><td style="width:211px">Metabolism and nutrition disorders</td><td style="width:125px">Hypokalemia</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Psychiatric disorders</td><td style="width:125px">Behavioural changes such as nervousness, insomnia and mood swings<br />Depression</td><td style="width:103px">Psychomotor hyperactivity<br />Anxiety</td><td style="width:102px">Aggression</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Nervous system disorders</td><td style="width:125px">&nbsp;</td><td style="width:103px">Tremor</td><td style="width:102px">&nbsp;</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Eye disorders</td><td style="width:125px">&nbsp;</td><td style="width:103px">&nbsp;</td><td style="width:102px">Cataract including subcapsular cataract<br />Glaucoma<br />Vision, blurred (see also section 4.4)</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Cardiac disorders</td><td style="width:125px">Palpitations</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Gastrointestinal disorders</td><td style="width:125px">Dyspepsia</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Skin and subcutaneous tissue disorders</td><td style="width:125px">Skin reactions (urticaria, exanthema)</td><td style="width:103px">&nbsp;</td><td style="width:102px">Ecchymosis</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Musculoskeletal and connective tissue disorders</td><td style="width:125px">Muscle cramps</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">&nbsp;</td></tr><tr><td style="width:211px">Reproductive system and breast disorders</td><td style="width:125px">Menstrual disorders</td><td style="width:103px">&nbsp;</td><td style="width:102px">&nbsp;</td><td style="width:167px">&nbsp;</td></tr></tbody></table><p>* Note that Cortiment is not recommended for use in children (see 4.2)<br />Most of the adverse events mentioned in this SmPC can also be expected for other treatments with&nbsp;glucocorticoids.</p><p>Side effects typical of systemic glucocorticosteroids (e.g. cushingoid features and growth retardation) may occur.<br />These side effects are dependent on dose, treatment time, concomitant and previous corticosteroid intake and&nbsp;individual sensitivity.</p><p><u>Paediatric population</u><br />No data available.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to the low systemic availability of budesonide, acute overdosage even at very high doses is not expected to lead to an acute clinical crisis. In the event of acute overdosage, no specific antidote is available. Treatment&nbsp;consists of supportive and symptomatic therapy.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Intestinal anti-inflammatory agents, Corticosteroids acting locally<br />ATC code: A07E A06<br /><u>Mechanism of action</u><br />The exact mechanism of action of budesonide in the treatment of UC and MC is not fully understood. In general, budesonide inhibits many inflammatory processes including cytokine production, inflammatory cell activation and expression of adhesion molecules on endothelial and epithelial cells. At doses clinically equivalent to prednisolone, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.<br />Data from clinical pharmacology and pharmacokinetic studies indicate that the mode of action of Cortiment tablets is based on a local action in the gut.<br /><u>Pharmacodynamic effects</u><br />MMX extended release technology is characterised by a multi-matrix structure covered by a gastro-resistant coating that dissolves in intestinal fluids having a pH greater than 7.When the dosage form is administered, the gastro-protective layer protects the dosage form during transit through the stomach and duodenum up to the lower part of the intestine. When the protective layer is lost the intestinal fluid then comes into contact with the hydrophilic matrix polymers, which start to swell until a viscous gel matrix is formed. The solvent that penetrates into the gel matrix dissolves the active ingredient from the lipophilic matrices. Budesonide is then released into the intestinal tract at a controlled rate throughout the colon.<br />Budesonide is a glucocorticoid used in the treatment of inflammatory bowel disease. It has a topical anti-inflammatory activity, but does not reduce cortisol levels to the same extent as systemic glucocorticoids.<br /><u>Clinical efficacy</u></p><p><u>Colitis ulcerosa:</u></p><p>Two randomised, controlled phase III clinical trials including 1022 patients with mild to moderate active UC have been performed in adult patients. Two hundred fifty five (255) patients were treated for 8 weeks with Cortiment 9 mg per day. Patients included were either treatment na&iuml;ve (42% ITT) or had failed on 5-ASA (58% ITT). Both studies included a reference arm, mesalazine (Asacol) and budesonide (Entocort), respectively to show assay sensitivity. The definition of remission applied in both studies was UCDAI score of &le;1, with 0 score for rectal bleeding and stool frequency, normal mucosa (no friability) and &ge;1 point reduction in endoscopy score.</p><p>Effect of Cortiment 9mg tablet on Primary Endpoint:</p><table border="1" cellspacing="1" cellpadding="1" style="width:354px"><tbody><tr><td style="width:157px">Study</td><td style="width:100px">Cortiment 9 mg Remission (%)</td><td style="width:65px">Placebo Remission (%)</td><td style="width:77px">P=</td></tr><tr><td style="width:157px">Study CB-01-02/01</td><td style="width:100px">17.9</td><td style="width:65px">7.4</td><td style="width:77px">0.0143</td></tr><tr><td style="width:157px">Study CB-01-02/02</td><td style="width:100px">17.4</td><td style="width:65px">4.5</td><td style="width:77px">0.0047</td></tr></tbody></table><p>Statistical difference versus placebo was reached for Cortiment 9 mg for both studies and the difference versus placebo was 10.4% and 12.9% respectively.<br />5-ASA is the Standard of Care for treatment of mild to moderate disease. Results of a head to head comparison with Cortiment and 5-ASA were not available. Therefore, the place in the therapeutic work-up remains to be established. Some patients may benefit from treatment initially with Cortiment.<br />Evidence for the indication microscopic colitis (collagenous colitis and lymphocytic colitis) is presented below. This evidence comes from studies on budesonide product Entocort. The systemic availability of this product is similar to that of budesonide product Cortiment (see section 5.2).</p><p><u>Collagenous colitis:</u><br />Two randomised, double-blind, placebo-controlled induction studies of six and eight weeks duration investigated the clinical and histological effects of budesonide 9 mg/day in the treatment of collagenous colitis. In the first study, 23 patients were randomised to budesonide 9 mg/day and 22 patients to placebo for 6 weeks. The rate of clinical remission was significantly higher (p&lt;0.001) in the budesonide group than in the placebo group 86.9% vs. 13.6%. Histologic improvement was observed in 14 patients of the budesonide group (60.9%) and in one patient of the placebo group (4.5%; p&lt;0.001). In the second study, 10 patients were randomised to budesonide for 8 weeks (9 mg/day 4 weeks, 6 mg/day 2 weeks, and 3 mg/day 2 weeks) and ten to placebo. All 10 patients receiving budesonide had a clinical response compared with two in the placebo group (p&lt;0.001).<br />Two open-label studies (run-in phase of randomised, double-blind, placebo-controlled maintenance studies) investigated the efficacy of budesonide 9 mg/day during 6 weeks. In the first study, 46 patients (96%) achieved clinical remission within 2&ndash;30 (mean 6.4) days, with marked improvements in stool consistency. In the second study, of the 42 patients who commenced the study, 34 patients (81%) were in clinical remission (mean stool frequency of three or fewer per day) at week 6.<br /><u>Lymphocytic colitis:</u><br />Evidence for this indication is limited. One randomised, double-blind placebo-controlled study was carried out in 15 lymphocytic colitis patients. Eleven subjects were treated with budesonide 9 mg/day and four patients received placebo for 8 weeks. A clinical response (defined as at least 50% improvement in the frequency of bowel movements) was seen in 25% of the placebo group vs. 91% in the budesonide group (p=0.03).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u><br />After oral dosing of plain micronised budesonide, absorption seems to be complete. A large proportion of the<br />unformulated drug is absorbed from the ileum and ascending colon.<br />Systemic availability of budesonide following a single administration of Cortiment tablets in healthy volunteers was compared to that of Entocort&reg; and the result was similar, about 10%, due to first pass metabolism in the liver. Maximum plasma concentrations of budesonide are approximately 1.3-1.8 ng/ml at 13-14 hours post administration. Concomitant administration of Cortiment tablets with food had no clinically relevant effect on absorption. It has been shown that there is no potential for drug accumulation on repeated dosing.<br /><u>Distribution</u><br />Budesonide has a high volume of distribution (about 3 L/kg). Plasma protein binding averages 85&ndash;90%.</p><p><u>Biotransformation</u><br />Budesonide undergoes extensive biotransformation in the liver to metabolites of low glucocorticoid activity. The glucocorticoid activity of the major metabolites, 6&beta;-hydroxybudesonide and 16&alpha;-hydroxy-prednisolone, is less than 1% of that of budesonide. The metabolism of budesonide is primarily mediated by CYP3A, a subfamily of cytochrome P450.<br /><u>Elimination</u><br />Elimination of budesonide is rate limited by absorption. Budesonide has a high systemic clearance (about 1.2 L/min).<br /><u>Paediatric Population</u></p><p>No data or experience is available with respect to the pharmacokinetics of Cortiment tablets in the paediatric population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A preclinical toxicology and toxicokinetic bridging study, comparing Cortiment tablets with an existing prolonged release budesonide formulation (Entocort&reg; EC 3 mg capsules, AstraZeneca) in cynomolgous monkeys has confirmed that Cortiment tablets result in a delayed peak exposure and reduced total exposure compared to the existing formulation of budesonide, while maintaining a superimposable toxicological profile.<br />Preclinical data have shown that budesonide produces effects less severe or similar to other glucocorticoids, such as weight increase, atrophy of the adrenal glands and thymus and effects on the leucocyte count. As with other glucocorticosteroids, and dependent on the dose and duration and the diseases concerned, these steroid effects may also be relevant in man.<br />Budesonide had no effect on fertility in rats. In pregnant rats and rabbits, budesonide, like other glucocorticosteroids, has been shown to cause foetal death and abnormalities of foetal development (smaller litter size, intrauterine foetal growth retardation and skeletal abnormalities). Some glucocorticoids have been reported to produce cleft palate in animals. The relevance of these findings to man has not been established (see also section 4.6).<br />Budesonide had no mutagenic effects in a number of in vitro and in vivo tests. A slightly increased number of basophilic hepatic foci were observed in chronic rat studies with budesonide, and in carcinogenicity studies an increased incidence of primary hepatocellular neoplasms, astrocytomas (in male rats) and mammary tumours (in female rats) were observed. These tumours are probably due to the specific steroid receptor action, increased metabolic burden and anabolic effects on the liver, effects which are also known from rat studies with other glucocorticosteroids and therefore represent a class effect in this species.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Tablet Core</strong><br />Stearic Acid<br />Lecithin (soya)<br />Microcrystalline cellulose<br />Hydroxypropylcellulose<br />Lactose Monohydrate<br />Silica, ColloidalHydrated<br />MagnesiumStearate (Ph. Eur.) [herbal]<br /><strong>Tablet Film-coating</strong><br />Methacrylic acid-methyl methacrylate copolymer (1:1) (Ph. Eur.)<br />Methacrylic acid-methyl methacrylate copolymer (1:2) (Ph. Eur.)<br />Talc<br />Titanium Dioxide<br />Triethyl citrate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The tablets are packaged in polyamide/ aluminium/ PVC foil blister packs with aluminium push through foil,contained in a cardboard carton.<br />Packs contain 10, 20, 30, 50, 60 or 80 tablets.<br />Not all pack sizes may be marketed.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ferring GmbH
Wittland 11
24109 Kiel
Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>